4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A DLL3-targeted ADC effectively targets pulmonary neuroendocrine tumor-initiating cells to result in sustained tumor regressions
    Meeting Abstract

    Saunders, L. R.; Bankovich, A. J.; Anderson, W. A.; Aujay, M.; Bheddah, S.; Black, K. A.; Desai, R.; Escarpe, P.; Hampl, J.; Park, A.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Rociletinib in NSCLC patients with negative central testing for T790M in TIGER-X
    Meeting Abstract

    Wakelee, H. A.; Sequist, L. V.; Gadgeel, S.; Soria, J. C.; Goldman, J. W.; Yu, H.; Camidge, D. R.; Solomon, B. J.; Matheny, S.; Despain, D.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Oncogenic drivers including RET and ROS1 plus PTEN loss and MET by IHC in patients with lung adenocarcinomas: Lung Cancer Mutation Consortium 2.0
    Meeting Abstract

    Johnson, B. E.; Kris, M. G.; Wistuba, I. I.; Berry, L.; Socinski, M. A.; Ramalingam, S. S.; Glisson, B.; Otterson, G.; Schiller, J.; Cetnar, J.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Characterization of MET gene and MET protein expression in lung cancer
    Meeting Abstract

    Boyle, T. A.; Lu, X.; Berry, L.; Ellison, K. E.; Kowalewski, A. A.; Rivard, C. J.; Khalil, F.; Mino-Kenudson, M.; Moreira, A.; Sholl, L.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Dose optimization of rociletinib for EGFR mutated NSCLC
    Meeting Abstract

    Goldman, J. W.; Wakelee, H. A.; Gadgeel, S.; Camidge, D. R.; Solomon, B. J.; Yu, H.; Oxnard, G. R.; Ou, S. H.; Papadimitrakopoulou, V.; Perol, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • T1a lung adenocarcinomas: Presence of spread of tumor through alveolar spaces (STAS), micropapillary and solid patterns determines outcomes
    Meeting Abstract

    Kadota, K.; Eguchi, T.; Rizk, N. P.; Woo, K. M.; Sima, C. S.; Park, B. J.; Jones, D. R.; Travis, W. D.; Adusumilli, P. S.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Multiple lung cancers: Is their survival better or worse then other lung cancers?
    Meeting Abstract

    Naidoo, J.; Woo, K.; Sima, C. S.; Travis, W. D.; Arcila, M.; Finley, D. J.; Rusch, V. W.; Jones, D. R.; Kris, M. G.; Zauderer, M.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Efficacy of pembrolizumab in key subgroups of patients with advanced NSCLC
    Meeting Abstract

    Hellmann, M. D.; Garon, E. B.; Gandhi, L.; Hui, R.; Zhang, J.; Rangwala, R.; Lubiniecki, G.; Rizvi, N. A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Pembrolizumab 2 mg/kg Q3W for previously treated, PD-L1-positive advanced NSCLC
    Meeting Abstract

    Fløtten, Ø.; Garon, E. B.; Arkenau, H. T.; Hui, R.; Gandhi, L.; Felip, E.; Lena, H.; Cappuzzo, F.; Horn, L.; Gubens, M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Initial analyses of the IASLC malignant pleural mesothelioma (MPM) database: Implications for the 8th Edition AJCC and UICC Staging Manuals
    Meeting Abstract

    Rusch, V.; Chansky, K.; Nowak, A.; Rice, D.; Kindler, H. L.; Pass, H.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save